UNIV ERASMUS has a total of 212 patent applications. Its first patent ever was published in 1971. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ASHKENAZI AVI J, ARCA BIOPHARMA INC and ALIENOR FARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 40 | |
#2 | WIPO (World Intellectual Property Organization) | 31 | |
#3 | United States | 30 | |
#4 | Australia | 28 | |
#5 | Canada | 18 | |
#6 | United Kingdom | 13 | |
#7 | Netherlands | 9 | |
#8 | China | 6 | |
#9 | New Zealand | 6 | |
#10 | Germany | 4 | |
#11 | France | 4 | |
#12 | Brazil | 3 | |
#13 | Japan | 3 | |
#14 | Belgium | 2 | |
#15 | Denmark | 2 | |
#16 | Hong Kong | 2 | |
#17 | Israel | 2 | |
#18 | Italy | 2 | |
#19 | Mexico | 2 | |
#20 | Sweden | 2 | |
#21 | Austria | 1 | |
#22 | Republic of Korea | 1 | |
#23 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Medical technology | |
#6 | Micro-structure and nano-technology | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Animal care | |
#8 | Diagnosis and surgery | |
#9 | Nanostructure applications | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Grosveld Frank | 17 |
#2 | Benner Robbert | 16 |
#3 | Khan Nisar Ahmed | 16 |
#4 | Langerak Anthonie Willem | 15 |
#5 | Van Dongen Jacobus Johannes Ma | 15 |
#6 | Van Dongen Jacobus Johannes Maria | 11 |
#7 | Osterhaus Albertus D M E | 9 |
#8 | Uitterlinden Andreas Gerardus | 9 |
#9 | Pols Huibert Adriaan Pieter | 8 |
#10 | Baalen Carel A Van | 8 |
Publication | Filing date | Title |
---|---|---|
GB0706628D0 | Germ-line manipulation 1 | |
GB0618345D0 | Binding molecules | |
WO2007123392A1 | Determining the replicative history of lymphocytes | |
WO2006046860A1 | Determining the replicative history of lymphocytes | |
GB0517714D0 | Selection method | |
WO2005080991A1 | Method to detect antigen-specific cytolytic activity | |
GB0423873D0 | Nucleic acid analysis | |
GB0418867D0 | Selection method | |
GB0416392D0 | Heavy chain immunoglobulin complexes | |
AU2003283864A8 | Detection of cellular or dna damage based upon hr23 protein binding molecules | |
AU2003283860A1 | Fret probes and methods for detecting interacting molecules | |
WO2004042398A1 | Method and probes for the detection of a tunor specific fusion protein | |
GB0325501D0 | Nucleic acids analysis | |
GB0324857D0 | Nucleic acid analysis | |
CA2501863A1 | Nucleic acid amplification primers for pcr-based clonality studies | |
GB0319938D0 | Selection method | |
EP1477802A1 | Method for selecting and producing vaccine components and vaccines based thereon | |
US7820374B2 | Detection methods based on HR23 protein binding molecules | |
BR0209205A | Nucleic acid analysis | |
CN1518559A | VHH single heavy chain antibody and method for its preparation in mammal |